26 Analysts Covering SpaceX Stock Rate It a Buy. Here's Why 8 Analysts Disagree

SpaceX shares are down 36% from their all-time high but remain valued at roughly $2 trillion, above the $1.77 trillion IPO market capitalization. Wall Street is sharply divided: 26 of 34 analysts rate the stock a buy, with targets ranging from Morningstar's $63 per share to Morgan Stanley's $300 and one $800 target implying more than 500% upside. The investment debate centers on whether SpaceX can scale its AI compute business, which represents about $26.5 trillion of its stated $28.5 trillion TAM; the article argues the current valuation already prices in much of this uncertain opportunity.

Analysis

The actionable signal is not directional SpaceX exposure but a valuation-dispersion warning: the equity case appears to require simultaneous execution across launch cadence, broadband monetization, and a capital-intensive compute platform. Those businesses have materially different unit economics and funding needs; bundling them into a single AI narrative can defer, rather than eliminate, the moment when investors demand segment-level margins, capex intensity, and return-on-invested-capital disclosure. A 36% drawdown is therefore not automatically a valuation reset if the forward model still capitalizes unproven terminal economics.

Near term (days to 1 month), treat published analyst targets as low-information until the listing status, share class, float, prospectus, and underlying research are independently verified; the article contains assertions that cannot be reconciled from the supplied data alone. Over 1-3 months, the relevant catalyst is credible disclosure separating recurring connectivity cash flow from launch and compute investment, not additional TAM rhetoric. Over 6-18 months, a sustained high-rate capex cycle would favor incumbent AI infrastructure providers with externally visible revenue and utilization—NVDA and AVGO—while pressuring speculative space/AI multiples if financing costs or satellite replacement requirements rise.

Contrarianly, the market may be underestimating the strategic value of a communications network with proprietary launch access, but that option value should be financed as a long-duration venture asset rather than valued like near-term AI revenue. The bull thesis is falsified by weaker subscriber net additions, declining broadband ARPU, launch delays, or evidence that compute economics cannot clear terrestrial power, cooling, and latency alternatives. The bear thesis is falsified by audited segment disclosure showing recurring communications FCF funding expansion capex and contracted enterprise/government demand converting into backlog.

Key Decisions for Investors

• No direct SPCX position until exchange listing, security identifier, float, and primary filing are independently verified; place an event-driven alert for audited segment revenue, capex, and cash-flow disclosure rather than trading on syndicated analyst commentary.
• For liquid AI exposure over the next 3-6 months, prefer a quality basket long NVDA and AVGO versus a short position in a high-beta, non-profitable space/communications proxy only after borrow, beta, and catalyst dates are confirmed. Target 2:1 expected payoff; stop if AI infrastructure order commentary weakens or the short leg secures material contracted revenue.
• Monitor MORN and MS research publication dates, methodology, and estimate revisions rather than price targets. A verified upward revision to recurring connectivity cash flow would be more investable than a higher AI TAM estimate; absent that, avoid chasing any relief rally driven by narrative multiple expansion.
• Watch RKLB, ASTS, and IRDM as read-throughs over 6-18 months: long IRDM versus speculative satellite operators is the cleaner defensive expression if capital-market conditions tighten, because recurring service revenue is more valuable than long-dated launch or constellation optionality. Reassess if funding conditions ease materially or launch economics demonstrate sustained cost deflation.